|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
2 |
0.340
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.296
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.278
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.236
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.227
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.212
|
Human |
|
|
vasculature development
|
GO:0001944 |
181 |
0.212
|
Human Zebrafish |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.196
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.195
|
Human |
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.193
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.182
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.175
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.172
|
Human Fly |
|
|
post embryonic development
|
GO:0009791 |
2 |
0.163
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.161
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.160
|
Human |
|
|
cell adhesion
|
GO:0007155 |
325 |
0.158
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
3 |
0.155
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.142
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
60 |
0.142
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.140
|
Human |
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.133
|
Human Fly |
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.132
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.126
|
Human Fly |
|
|
viral process
|
GO:0016032 |
146 |
0.123
|
|
|
|
striated muscle contraction
|
GO:0006941 |
52 |
0.121
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.120
|
Human Zebrafish |
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.118
|
Human Zebrafish |
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.117
|
Human Zebrafish |
|
|
biological adhesion
|
GO:0022610 |
331 |
0.114
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.110
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.109
|
Human Zebrafish |
|
|
muscle contraction
|
GO:0006936 |
73 |
0.109
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.108
|
Human |
|
|
muscle system process
|
GO:0003012 |
81 |
0.107
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
34 |
0.107
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.107
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.101
|
|
|
|
regulation of pathway restricted smad protein phosphorylation
|
GO:0060393 |
34 |
0.100
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.099
|
Human |
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.099
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.098
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.096
|
Human |
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.096
|
Human |
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.096
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.093
|
|
|
|
system process
|
GO:0003008 |
349 |
0.093
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.092
|
Human |
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.092
|
Human |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.091
|
Human Fly |
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.090
|
Human |
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.089
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
48 |
0.087
|
Human |
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.087
|
Human |
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.085
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.084
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.084
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.082
|
Human |
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.082
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.081
|
Human |
|
|
hard palate development
|
GO:0060022 |
1 |
0.080
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.079
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.079
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
45 |
0.079
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.078
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.078
|
Human |
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.078
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.078
|
Human |
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
29 |
0.076
|
Human |
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.076
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.076
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.076
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.076
|
Human |
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.074
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.074
|
Human |
|
|
cell development
|
GO:0048468 |
328 |
0.074
|
Human |
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.074
|
Human |
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.073
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.073
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.073
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.072
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.071
|
Human |
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.070
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.070
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.069
|
|
|
|
negative regulation of pathway restricted smad protein phosphorylation
|
GO:0060394 |
11 |
0.069
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.068
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.068
|
Human |
|
|
tube development
|
GO:0035295 |
125 |
0.068
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
52 |
0.068
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.067
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.067
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.067
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.067
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.067
|
Human |
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.066
|
Human |
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
33 |
0.066
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.066
|
Human |
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.066
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.065
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
32 |
0.065
|
Human |
|
|
potassium ion transmembrane transport
|
GO:0071805 |
60 |
0.064
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.064
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
28 |
0.064
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.064
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.063
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
94 |
0.063
|
Human |
|
|
protein processing
|
GO:0016485 |
226 |
0.063
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.063
|
|
|
|
late endosome to vacuole transport
|
GO:0045324 |
2 |
0.062
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.062
|
Human |
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.062
|
Human |
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.062
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.062
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.062
|
Human |
|
|
receptor catabolic process
|
GO:0032801 |
11 |
0.061
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.061
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.061
|
Human |
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.060
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.060
|
Human |
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.059
|
|
|
|
regulation of activin receptor signaling pathway
|
GO:0032925 |
14 |
0.059
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.058
|
Human |
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.058
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.058
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.058
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.057
|
Human |
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.057
|
Human |
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.057
|
Human |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.057
|
Human |
|
|
negative regulation of sodium ion transport
|
GO:0010766 |
3 |
0.057
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.057
|
Human |
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.056
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.056
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.055
|
Human |
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.055
|
Human |
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.055
|
|
|
|
positive regulation of proteasomal protein catabolic process
|
GO:1901800 |
35 |
0.055
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.055
|
Human |
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.055
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.055
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.054
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.054
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.054
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.054
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.053
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.053
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.053
|
Human |
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.053
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.053
|
Human |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.053
|
|
|
|
regulation of mesoderm development
|
GO:2000380 |
4 |
0.052
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.052
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.052
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.052
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.051
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.051
|
|
|
|
negative regulation of sodium ion transmembrane transporter activity
|
GO:2000650 |
2 |
0.051
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.051
|
Human |
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.051
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.051
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
53 |
0.051
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.050
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.050
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.050
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.050
|
Human |
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.050
|
Human |
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.049
|
|
|
|
avoidance of defenses of other organism involved in symbiotic interaction
|
GO:0051832 |
2 |
0.049
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.049
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.048
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.048
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
20 |
0.048
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.048
|
Human |
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
7 |
0.048
|
|
|
|
sodium ion transport
|
GO:0006814 |
61 |
0.048
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.047
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.047
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.047
|
|
|
|
response to host defenses
|
GO:0052200 |
2 |
0.047
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.047
|
|
|
|
smad protein complex assembly
|
GO:0007183 |
12 |
0.047
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.046
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.046
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.046
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.046
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.046
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.046
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.046
|
Human |
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.046
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.045
|
|
|
|
evasion or tolerance of host defenses
|
GO:0044415 |
2 |
0.045
|
|
|
|
heart contraction
|
GO:0060047 |
62 |
0.045
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.045
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.044
|
Human |
|
|
taxis
|
GO:0042330 |
157 |
0.044
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.044
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.044
|
Human |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.044
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.043
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.043
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.043
|
Human |
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.043
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.043
|
|
|
|
growth
|
GO:0040007 |
202 |
0.043
|
Human |
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
41 |
0.043
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
76 |
0.042
|
Human |
|
|
metal ion transport
|
GO:0030001 |
272 |
0.042
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.042
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.042
|
Human |
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.042
|
Human |
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.041
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.041
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.041
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.041
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.041
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.041
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.041
|
Human |
|
|
stem cell development
|
GO:0048864 |
69 |
0.041
|
Human |
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.041
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.041
|
Human |
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.040
|
Human |
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.040
|
Human |
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.040
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.040
|
Human |
|
|
ribonucleoprotein complex export from nucleus
|
GO:0071426 |
4 |
0.040
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.040
|
Human |
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.040
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
75 |
0.040
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
39 |
0.040
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
33 |
0.040
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.039
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.039
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.039
|
Human |
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.039
|
Human |
|
|
renal system development
|
GO:0072001 |
63 |
0.039
|
Human |
|
|
skeletal system development
|
GO:0001501 |
79 |
0.039
|
Human |
|
|
cell fate determination
|
GO:0001709 |
3 |
0.038
|
Human |
|
|
activin receptor signaling pathway
|
GO:0032924 |
24 |
0.038
|
|
|
|
potassium ion transport
|
GO:0006813 |
62 |
0.038
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
76 |
0.038
|
Human |
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.038
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
65 |
0.038
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
84 |
0.038
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.038
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.037
|
|
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.037
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.037
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.037
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
37 |
0.037
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.037
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
45 |
0.037
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.037
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.037
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.036
|
Human |
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
23 |
0.036
|
Human |
|
|
endocardial cushion development
|
GO:0003197 |
3 |
0.036
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.036
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.036
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.036
|
Human |
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.036
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.036
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
59 |
0.036
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.036
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.036
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.035
|
Human |
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.035
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.035
|
|
|
|
positive regulation of mesoderm development
|
GO:2000382 |
2 |
0.035
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.035
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.035
|
Human |
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.035
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.035
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.034
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.034
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.034
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.034
|
Human |
|
|
heart development
|
GO:0007507 |
95 |
0.034
|
Human |
|
|
response to host
|
GO:0075136 |
2 |
0.034
|
|
|
|
rrna containing ribonucleoprotein complex export from nucleus
|
GO:0071428 |
4 |
0.034
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.033
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.033
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.033
|
Human |
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.033
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.033
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.033
|
|
|
|
pathway restricted smad protein phosphorylation
|
GO:0060389 |
38 |
0.033
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
26 |
0.033
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.033
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.033
|
|
|
|
forebrain regionalization
|
GO:0021871 |
3 |
0.033
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.032
|
Human |
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.032
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.032
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.032
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.032
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.032
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.032
|
Human |
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.032
|
Human |
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.032
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.032
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.032
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
1 |
0.031
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.031
|
Human |
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
54 |
0.031
|
|
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.031
|
|
|
|
interaction with host
|
GO:0051701 |
42 |
0.031
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.031
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.031
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.031
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.031
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.031
|
Human |
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.031
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.030
|
Human |
|
|
regulation of cell cell adhesion
|
GO:0022407 |
57 |
0.030
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.030
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
50 |
0.030
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
37 |
0.030
|
|
|
|
lateral mesoderm development
|
GO:0048368 |
1 |
0.030
|
|
|
|
positive regulation of pathway restricted smad protein phosphorylation
|
GO:0010862 |
22 |
0.030
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.030
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.030
|
|
|
|
ribosomal subunit export from nucleus
|
GO:0000054 |
4 |
0.030
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.030
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.030
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.030
|
Human |
|
|
regulation of isoprenoid metabolic process
|
GO:0019747 |
1 |
0.030
|
|
|
|
evasion or tolerance of host defenses by virus
|
GO:0019049 |
2 |
0.029
|
|
|
|
response to cholesterol
|
GO:0070723 |
11 |
0.029
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.029
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.029
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.029
|
|
|
|
regulation of ribosome biogenesis
|
GO:0090069 |
1 |
0.029
|
|
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
20 |
0.029
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.029
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.029
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.029
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.029
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.029
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.029
|
Human |
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.028
|
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.028
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.028
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.028
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.028
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.028
|
Human |
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.028
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.028
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.028
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.028
|
|
|
|
heart process
|
GO:0003015 |
62 |
0.028
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
14 |
0.028
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.027
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
37 |
0.027
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
50 |
0.027
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.027
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.027
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
71 |
0.027
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.027
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.027
|
Human |
|
|
cardiac septum morphogenesis
|
GO:0060411 |
9 |
0.027
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.027
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.027
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
72 |
0.027
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.027
|
|
|
|
ectodermal placode formation
|
GO:0060788 |
1 |
0.027
|
|
|
|
coenzyme biosynthetic process
|
GO:0009108 |
24 |
0.027
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.027
|
Human |
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.027
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.027
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
1 |
0.027
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.027
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.027
|
Human |
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
2 |
0.027
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
23 |
0.026
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.026
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
78 |
0.026
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.026
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.026
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.026
|
Human |
|
|
regulation of blood circulation
|
GO:1903522 |
59 |
0.026
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.026
|
Human |
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.026
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.026
|
Human |
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.026
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.026
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.026
|
Human |
|
|
muscle cell fate commitment
|
GO:0042693 |
4 |
0.026
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.026
|
Human |
|
|
tissue migration
|
GO:0090130 |
119 |
0.026
|
Human |
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.026
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.026
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.026
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
28 |
0.025
|
|
|
|
ectodermal placode development
|
GO:0071696 |
1 |
0.025
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.025
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.025
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.025
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.025
|
Human |
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.025
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
17 |
0.025
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.025
|
Human |
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.025
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.025
|
Human |
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.025
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.025
|
Human |
|
|
regeneration
|
GO:0031099 |
4 |
0.025
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.025
|
Human |
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.025
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.025
|
Human |
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.025
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.025
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
87 |
0.025
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.025
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.025
|
Human |
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.025
|
Human |
|
|
regulation of mrna export from nucleus
|
GO:0010793 |
3 |
0.025
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.025
|
|
|
|
regulation of potassium ion transmembrane transporter activity
|
GO:1901016 |
16 |
0.024
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.024
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.024
|
Human |
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.024
|
|
|
|
autophagy
|
GO:0006914 |
88 |
0.024
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.024
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.024
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.024
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.024
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.024
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.024
|
Human |
|
|
response to lipid
|
GO:0033993 |
206 |
0.024
|
Human |
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.024
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.024
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.024
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.023
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.023
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.023
|
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.023
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.023
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.023
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.023
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.023
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.023
|
Human |
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.023
|
|
|
|
regulation of muscle organ development
|
GO:0048634 |
27 |
0.023
|
|
|
|
ubiquitin dependent endocytosis
|
GO:0070086 |
1 |
0.023
|
|
|
|
regulation of endosome size
|
GO:0051036 |
3 |
0.023
|
|
|
|
determination of left right asymmetry in lateral mesoderm
|
GO:0003140 |
1 |
0.023
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.023
|
|
|
|
negative regulation of ion transmembrane transport
|
GO:0034766 |
26 |
0.023
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.023
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.022
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.022
|
Human |
|
|
endosome transport via multivesicular body sorting pathway
|
GO:0032509 |
3 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.022
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
45 |
0.022
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.022
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.022
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.022
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.022
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
1 |
0.022
|
|
|
|
cardiac septum development
|
GO:0003279 |
13 |
0.022
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
48 |
0.022
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.022
|
|
|
|
mitral valve development
|
GO:0003174 |
3 |
0.022
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.022
|
Human |
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.022
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
67 |
0.022
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
41 |
0.021
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.021
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.021
|
|
|
|
ketone biosynthetic process
|
GO:0042181 |
17 |
0.021
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.021
|
Human |
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.021
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.021
|
|
|
|
fat cell differentiation
|
GO:0045444 |
32 |
0.021
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.021
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.021
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.021
|
Human |
|
|
protein import
|
GO:0017038 |
130 |
0.021
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.021
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.021
|
|
|
|
positive regulation of mesenchymal stem cell differentiation
|
GO:2000741 |
4 |
0.021
|
Human |
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.021
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.021
|
Human |
|
|
cofactor biosynthetic process
|
GO:0051188 |
31 |
0.021
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.021
|
Human |
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
55 |
0.021
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.020
|
|
